🚀 go-pugleaf

Header: Executive Summary & Press Release

Updated: July 16, 1995

Subject: Zap & Cap/Kap (TM) Laser Assisted Corneal Inlays and
Lasertome(TM) Lasers to Eliminate or Reduce the Need for Eyeglasses and
Contact Lenses.
Organization: MINDSOURCE(R)

Introduction:

Mindsource(R) has recently received the license to commercially develop
and distribute a naturally or synthetically derived contact-like Lens that
permanently bonds on to the cornea of the eye ie  �A Living Contact
Lens(TM).� The surface of the cornea in one embodiment may be Laser milled
to form a shallow recess to accept either a Natural or Synthetic Lens
derived by laser or other means.  The lens is permanent but can be peeled
off in the event one's eye prescription changes to be replaced by a new
inlay. 

The lens material may be derived from: the patient's own tissue, donor
tissue, natural or synthetically derived sources.

Although at this stage for synthetic materials the concept as a whole must
still be considered experimental and not FDA approved, the embodiments
using naturally derived cornea and other components such as eg Lasers are
FDA approved or are near approval.

This patented procedure and its components would only take a few minutes
to perform and replaces contact lenses and eyeglasses of any optical power
or configuration.  The Materials and Procedure have been trademarked as 
Zap & Cap/Kap(TM) and the laser is commercially called Lasertome(TM).

The market is estimated to be $100 Billion in the USA alone. 
Mindsource(R) will be assisting in the formation of a new company that
will raise $1 Billion by releasing an initial undetermined % of the
company's ownership to begin with.  

This is a rare opportunity for interested parties to provide valuable
skills and/or resources.

Company Description:
MINDSOURCE(R) is currently a wholly owned proprietorship and holding
company for the intellectual properties and businesses of Seymour P. Kern,
B.E.E., M.D. and Estate

Mindsource(R) Mission Statement: 
Use a multidisciplinary approach towards innovative research, expedited
commercial development and marketing byproducts of technology initially to
replace or reduce the need for eyeglasses or contact lenses and other
significant eye related problems.
Once underway, MINDSOURCE(R) will apply its vast information and human
resources towards solving a wide and diversified range of crucial
biomedical and other engineering problems for the betterment of mankind.

Stage of Development:
MINDSOURCE(R) has been actively engaged in bio-engineering since 1990. 
With respect to vision engineering, MINDSOURCE(R) is licensed by Dr.
Seymour P. Kern to manage the sublicensing of US Patent No. 4,676,790
Filed Sept 25, 1985 and issued June 30, 1987 and other patents and
trademarks to follow. Most if not all of the ingredients used which
includes Lasers, lenses and other materials have been approved or are in
the last stages of approval by the FDA.

Products and Services:
This broad patent, the first of a series, effectively describes a type of
contact lens either natural or synthetically derived that virtually �comes
alive� as it bonds on to the surface of the cornea previously laser
milled.  This relatively painless 5-10 minute outpatient procedure and
it�s components have been trademarked as Zap & Cap/Kap.(TM) 
(C is for Contact-like  lens, Laser and/or other prepared means) and (K is
for Kera or host cornea, prepared by Laser and/or other means)  all
referred to as Laser Assisted Corneal Inlays.   Should the patient�s
prescription change in time, the lens may be peeled off the cornea to be
similarly replaced by another lens. The synthetically and various
naturally derived embodiments eliminate or reduce the need for more
hazardous procedures that have prevented many ophthalmologists from
performing refractive surgery eg. Radial Keratotomy, Keratomileusis or the
like.  The most extreme conditions of Nearsightedness, Astigmatism and
also Farsightedness heretofore difficult to perform exclusively with
corneal ablative lasers will be no match for Zap & Cap/Kap.(TM) 

Target Markets:
All eye physicians, contact lens, eyeglass and laser manufacturers that
wish to safely diversify and prepare for the future.

Marketing and Sales Strategy:
MINDSOURCE(R) will concentrate much of its efforts in developing and
acquiring a wide selection of intellectual property via a network of
Mindsource Associates around the globe using a three part formula of
1.  Relationships - Forming relationships with human resource.
2.  Tools of Communication - Utilization of Communications to     
     propagate and maintain relationships.
3.  Applications: eg. Zap & Cap/Kap,(TM), Lasertome(TM) Variable Focal
Molecular        
     Optics,  Aids and Cancer Research, Internet Communications, Online    
     Research, etc. just to mention a few of virtually unlimited other
applications.

Competitors and Market Distribution:
MINDSOURCE(R) believes in the concept of networking with all sources
including competitors whereby all stand to benefit. Thus competitors
become eventually part of the MINDSOURCE(R) system. As such, the larger
MINDSOURCE(R) grows, the more valuable it becomes to each of its
participants.  Using a unified approach without reinventing the wheel, we
have rapidly become a powerful concern to others who are outside our
circle of participants.  We invite all competitors to join us in unified
strength.

Competitive Advantages and Distinctions:
MINDSOURCE(R)  as demonstrated in Zap & Cap/Kap(TM) believes in simple,
convenient and economical solutions and addressing significant needs to
secure its position in the marketplace.  Due to a vast communication
network of Mindsource Associate Librarians, MINDSOURCE(R) is in a most
unique position to develop an endless and diversified arsenal of
technology heretofore difficult to acquire via conventional structures.

Management:
MINDSOURCE(R) by its unique position on the information highway has made
it possible to attract the finest management team.   It is guided by its
founder, Seymour P. Kern, B.E.E., M.D. who utilizes a multidisciplinary
higher order approach towards accessing and directing top level management
from leading public and private companies that will participate.

Operations:
MINDSOURCE(R) operations are directed from its vast internet
communication  network headquartered in Carlsbad, California.   As such it
is possible to maintain virtually an infinite stable of technology with a
minimal amount of overhead expenses.   Human resources are thus accessed
on a per need basis without the need to hire full time expertise.  Much of
central headquarter�s activity will be devoted to generating and securing
intellectual property for licensure utilizing the very finest business and
legal counsel around the world.  

Financials:
MINDSOURCE(R) expects its participants to be in a profitable state
virtually from day one.  In a matter of a few days of release, Mindsource
was experiencing a steady flow of strong requests from both the general
public and industry for information and supply of materials.  Conservative
estimates of the market in the U.S. alone is $100 Billion with over
hundred million candidates.  It is believed that the lenses will sell
initially for approximately $1000 per pair to physicians who will probably
charge anywhere from $2000 to $3000 for bilateral procedures per
patient.   

Long-Term Goals:
MINDSOURCE(R) principal concept is that �The greatest untapped resource is
human resource.�  Its long term goal is to provide a fertile and user
friendly multidisciplinary atmosphere for all innovators of all
background.  This will stimulate many talented innovators to safely share
their valuable ideas towards ultimate licensure of a wide range of
intellectual property in a time and cost effective manner without
reinventing the wheel.

Funds Sought and Exit Strategy:
MINDSOURCE(R) seeks $1 Billion and believes in the wisdom that one should
�Always deal from a position of strength.� With a market of $100 Billion
in the US alone our goal would be to raise 1% of the market or $1 Billion
in increments of $100,000,000 into an intellectual property licensing
bank.  There would be sufficient reserves to safely satisfy all investors
from the shortest to longest term.   Even at a pessimistic 1% market share
with a 90% reduction of lens price we conservatively estimate $100 million
in gross sales per year as the worst possible scenario.  This will
conservatively allow rapid exit for the short term investor while
providing confidence for the long term investor.

Addendum 

We are in the process of adapting commercial lasers to manufacture and
perform the procedure Zap & Cap/Kap(TM) Laser assisted corneal inlays.  
The Laser is called Lasertome(TM). Mindsource owns the exclusive license
for the process patent and other patents to follow and will be raising an
initial $20,000,000 
in capital to kick it all off.

Most of this capital will be raised privately prior to going public
shortly thereafter as Mindsource, Inc.

We are now accepting applications from potential physician investigators
who will license use of the technology and marketing support by
individually purchasing $1,000,000 in Mindsource shares.  Mindsource will
provide convenient financing by lending  them the money with 5% down or
the like and 1% per month interest only thereafter plus a per lens
utilization cost to be determined. The loan may be secured by the shares
held in trust as collateral until paid off or sold on the open market.

Mindsource hopes to generate about $1 Billion in investments ultimately. 

As a matter of interest, the technique of "Flap and Zap" or "LASIK" is a
method that is also covered by broad claims made by the same patent
describing Zap & Cap/Kap(TM),  (pronounced: "zap and cap"), trademark for
Laser Assisted Corneal Inlays.

In the case of LASIK, the source of the inlay is the patient's own tissue.
Companies that are promoting or physicians utilizing Devices such as ALK or
the like to perform, LACI(TM),  Laser Assisted Corneal Inlays may actually be
potential infringers.

The essence of the Mindsource(R) patent is that the laser is used in
conjunction with other means to effect a corneal inlay, hence the phrase:
Laser Assisted Corneal Inlays now collectively trademarked as Zap &
Cap/Kap(TM) and/or LACI(TM).  LASERTOME(TM) is also the trademark for any Laser
manufactured or distributed by Mindsource used for this or other purposes.

The above may be a matter of concern to any company providing equipment,
training, or materials or to any physician performing laser assisted
corneal inlays without license from Mindsource(R).

Mindsource(R), therefore, wishes to negotiate a mutually supportive and
ethical means for licensure by forming a productive alliance of both
prospective clinical investigators and commercial sponsors.  We thus wish
to further the state of the art for this and other significant
biotechnology to follow in a atmosphere conducive to creative innovation.

It is strongly recommended that any companies or physicians involved past,
present or future in promoting or utilizing any form of laser assisted
corneal inlays (Products or Procedures) should contact Mindsource(R) at the
earliest possible convenience.

In short, Mindsource wants all innovators to be protected and rewarded for
their intellectual property and be further encouraged.  It has thus
established the Mindsource(R) Inventors Network on the Internet which may be
accessed by e-Mail or Internet at spk@cts.com or World Wide Web Page URL
Address:
http://www.webassist.com/webassist/mindsource/

For enquiries contact:
MINDSOURCE(R)
(Medical & Industrial Network Development(TM))
An Intellectual Property Think Tank of 
Relationships-
Placing People and their Resources in Touch with One Another by Means of a
User Friendly Network of Living Networks Around the World(TM)

Karen J. Schlonsky, Public Relations
P.O. Box 2725
Carlsbad, CA 92018
USA
Tel No. 619-931-9318, 931-9326 Messages
Fax 619-931-9322
Voice Pager 619-989-9696
WWW:  http://www.webassist.com/webassist/mindsource/
EMail: spk@cts.com (Preferred Means of Communication)

The Mindsource Concept:  "The greatest untapped resource is Human Resource."
Zap & Cap/Kap(TM), LACI(TM), LASERTOME(TM) are trademarks of Mindsource.
Mindsource is a registered trademark.
Copyright (c) 1995 by Mindsource
**********************************************************************